Coherus Biosciences

About:

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Website: http://www.coherus.com

Twitter/X: coherus_bio

Top Investors: RA Capital Management, F-Prime Capital, Sofinnova Investments, Kohlberg Kravis Roberts, HealthCare Royalty Partners

Description:

Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.